Table 1.
Time of assessment | |||||
---|---|---|---|---|---|
Screening | Baseline | Post treatment assessment | 6-month Follow-up | 12-month Follow- up |
|
Primary outcomes | |||||
Psychological distress: BSI-53 | X | X | X | X | |
Health-related quality of life: EQ-5D-5 L | X | X | X | X | |
Medical consumption & costs | X | X | X | X | |
Secondary outcomes | |||||
Life satisfaction: Cantril’s Ladder | X | X | X | X | |
Mental wellbeing: WEMWBS | X | X | X | X | |
Personality functioning: SIPP-SF | X | X | X | X | |
Interoceptive body awareness: MAIA | X | X | X | X | |
Psychotropic drug use & treatment received | |||||
Mood variability: Mood-Zoom | X | X | X | X | |
Characteristics | |||||
Personality disorders: SCID-5-PD Cluster B & C | X | ||||
Mental disorders: MINI-Plus | X | ||||
Cognitive screening: MoCA | X | ||||
Psychiatric treatment history: telephone interview | X | ||||
Socio-demographics: telephone interview | X | ||||
Chronic illnesses: LASA questionnaire | X | ||||
Early life-events: NEMESIS questionnaire | X | ||||
Alcohol use: AUDIT | X | ||||
Current smoking: NEMESIS questions | X | ||||
Physical activity: NEMESIS question | X | ||||
Personality traits: PID-5-SF | X |